This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

FBR Media Nominated For Three 2012 Emmy® Awards

Two episodes in FBR Media's new television series Bench to Bedside™ have been nominated for three prestigious Emm y® Awards

WASHINGTON, Nov. 20, 2012 /PRNewswire-USNewswire/ -- FBR Media announced today two episodes from its new television series Bench to Bedside™ have been nominated for three 2012 Midsouth Emmy® Awards. "Liviya's Story" received two nominations in the documentary/cultural and director/program categories. "Laura's Story" received a nomination in the public affairs category.  Executive producers Paul McKellips and Frankie Trull, producer/director Liz Hodge and director of photography/editor Steve Dorst are nominated. FBR Media has received seven Emmy® nominations for its Bench to Bedside™ TV series.

"FBR Media is extremely honored to receive three Emmy® nominations for our Bench to Bedside™ episodes on diabetes and aplastic anemia," said FBR Media president Paul McKellips. "These nominations honor the researchers, who are dedicating their lives to developing new treatments for these conditions."

"Liviya's Story" is the real account of a North Carolina girl named Liviya, who is battling a rare and potentially fatal blood disease called aplastic anemia, and horses that ultimately come to her rescue.  This episode features the University of North Carolina - Chapel Hill, the National Institutes of Health, the American Red Cross and the Carolina Hurricanes of the National Hockey League."Laura's Story" showcases cutting-edge diabetes research at Vanderbilt University Medical Center in Nashville, Tennessee, that could be a game-changer for the diabetes epidemic in the United States. 

Bench to Bedside™ is a new television series produced by FBR Media about inspirational people and animals living with serious illnesses and incredible biomedical research that could save their lives. Filmed documentary-style, Bench to Bedside™ is about true stories, real diseases and high stakes; where science meets reality TV.  Bench to Bedside™ is licensed by the Australian Broadcasting Corporation and the first season will air worldwide in 2013. 

The Nashville/Midsouth Chapter of the National Academy of Television Arts and Sciences will announce the winners at the 27 th Emmy® Awards banquet on January 26, 2013, in Nashville, TN.

FBR Media is an award-winning production studio that creates striking digital content across multiple platforms. Its latest TV series, Bench to Bedside , tells inspirational true stories about people and animals living with serious illnesses and the incredible biomedical research that could save their lives. FBR Media is a registered trademark of the Foundation for Biomedical Research. For more information visit:


Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs